Table 4.

Mean percentages of patients with T2D achieving target HbA1c levels

Patients	Total health districts	LGA 1	LGA 2	LGA 3	LGA 4
Total	57.1 (56.7, 57.4)	58.2 (57.7, 58.6)	63.0 (62.5, 63.6)	61.4 (60.5, 62.4)	54.2 (53.7, 54.7)
Sex
Male	55.5 (55.1, 55.8)	58.4 (57.7, 59.2)	60.3 (59.6, 61.1)	60.2 (59.3, 61.1)	52.3 (51.8, 52.9)
Female	59.2 (58.8, 59.6)	58.0 (57.6, 58.3)	66.7 (66.2, 67.3)	63.5 (62.3, 64.7	56.5 (56.1, 57.0)
BMI
BMI≥30	56.5 (56.0, 56.9)	55.5 (55.1, 55.9)	63.1 (62.5, 63.8)	58.0 (57.1, 58.8)	54.2 (53.5, 54.8)
BMI<30	57.7 (57.3, 58.0)	60.6 (60.0, 61.2)	62.9 (62.5, 63.4)	65.6 (64.4, 66.8)	54.2 (53.8, 54.6)
Age (years)
18–54	51.4 (50.8, 51.9)	56.9 (55.2, 58.6)	63.4 (62.4, 64.3)	46.8 (45.5, 48.0)	47.6 (46.8, 48.5)
55–74	56.3 (55.9, 56.8)	55.7 (55.2, 56.1)	62.3 (61.6, 62.9)	60.4 (59.4, 61.5)	54.1 (53.6, 54.6)
75+	63.6 (63.3, 65.0)	62.8 (62.2, 63.4)	64.6 (64.3, 65.0)	67.8 (66.3, 69.2)	62.7 (62.4, 62.9)

Mean percentages of active patients with type 2 diabetes mellitus who achieved the target level for HbA1c from September 2020 to June 2022. Data are percentage of eligible patients (95% CI). Target level for HbA1c ≤7%.

BMI, body mass index; LGA, local government area; T2D, type 2 diabetes.